Your browser doesn't support javascript.
loading
Could 18-FDG PET-CT Radiomic Features Predict the Locoregional Progression-Free Survival in Inoperable or Unresectable Oesophageal Cancer?
De Bari, Berardino; Lefevre, Loriane; Henriques, Julie; Gatta, Roberto; Falcoz, Antoine; Mathieu, Pierre; Borg, Christophe; Dinapoli, Nicola; Boulahdour, Hatem; Boldrini, Luca; Valentini, Vincenzo; Vernerey, Dewi.
Affiliation
  • De Bari B; Radiation Oncology Department, Neuchâtel Hospital Network, CH-2300 La Chaux-de-Fonds, Switzerland.
  • Lefevre L; Radiation Oncology Department, University Hospital of Besançon, F-25000 Besancon, France.
  • Henriques J; Radiation Oncology Department, University Hospital of Besançon, F-25000 Besancon, France.
  • Gatta R; Radiation Oncology Department, Centre Eugène Marquis, F-35042 Rennes, France.
  • Falcoz A; INSERM, Établissement Français du Sang Bourgogne Franche-Comté, UMR1098, Interactions Hôte-Greffon-Tumeur/Ingénierie Cellulaire et Génique, Bourgogne Franche-Comté University, F-25000 Besancon, France.
  • Mathieu P; Methodology and Quality of Life Unit in Oncology, University Hospital of Besançon, F-25000 Besancon, France.
  • Borg C; Dipartimento di Scienze Cliniche e Sperimentali, Università degli Studi di Brescia, I-25123 Brescia, Italy.
  • Dinapoli N; INSERM, Établissement Français du Sang Bourgogne Franche-Comté, UMR1098, Interactions Hôte-Greffon-Tumeur/Ingénierie Cellulaire et Génique, Bourgogne Franche-Comté University, F-25000 Besancon, France.
  • Boulahdour H; Methodology and Quality of Life Unit in Oncology, University Hospital of Besançon, F-25000 Besancon, France.
  • Boldrini L; Department of Digestive Surgery and Liver Transplantation, University Hospital of Besançon, F-25000 Besancon, France.
  • Valentini V; INSERM, Établissement Français du Sang Bourgogne Franche-Comté, UMR1098, Interactions Hôte-Greffon-Tumeur/Ingénierie Cellulaire et Génique, Bourgogne Franche-Comté University, F-25000 Besancon, France.
  • Vernerey D; Department of Medical Oncology, University Hospital of Besançon, F-25000 Besancon, France.
Cancers (Basel) ; 14(16)2022 Aug 22.
Article in En | MEDLINE | ID: mdl-36011035
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies / Risk_factors_studies Language: En Journal: Cancers (Basel) Year: 2022 Document type: Article Affiliation country: Suiza Country of publication: Suiza
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies / Risk_factors_studies Language: En Journal: Cancers (Basel) Year: 2022 Document type: Article Affiliation country: Suiza Country of publication: Suiza